On April 22, 2026, the U.S. Department of Justice (DOJ) issued a final order reclassifying certain marijuana-related products under the Controlled Substances Act (CSA). The order places (1) FDA-approved marijuana-derived drug products and (2) marijuana produced and dispensed pursuant to
The Blunt Truth®
A blog chronicling the evolution and implementation of cannabis laws in the United States
The Blunt Truth®, published by Seyfarth Shaw LLP, focuses on legal developments and regulatory issues related to cannabis and hemp industries. The blog covers topics such as federal and state cannabis legislation, regulatory compliance, labor peace agreements in cannabis licensing, enforcement actions, and litigation trends. It also reports on market developments including retail cannabis frameworks, hemp bans, and rescheduling efforts under controlled substances law. The blog provides updates on court rulings, legislative proposals, and administrative policies affecting cannabis businesses and stakeholders, with a particular emphasis on the intersection of cannabis law and labor, regulatory enforcement, and federal-state legal conflicts.
Latest from The Blunt Truth® - Page 3
The Week in Weed: May 22 , 2026
Flying High: TSA Permits Transport of Medical Marijuana
In an update perhaps better suited for April 20, on April 27, the Transportation Security Administration (“TSA”) added medical marijuana to the list of items permitted to be included both in carry on and checked baggage on flights. The policy…
The Week in Weed: April 24, 2026
CANNABIS RESCHEDULED!
Whether it was Roger Stone or Donald Trump who finally lit a fire under the Drug Enforcement Administration (DEA) to move cannabis from Schedule I to Schedule III, it’s finally happening. See the Department of Justice (DOJ) press release here…






